- UAE drug market expenditure was AED 2.17bn ($ 0.74bn) in 2007 and expected to reach AED 4.13bn ($ 1.12bn) by the end of 2012
- Pharmaceutical market has high growth potential due to stable and favorable regulatory and political environment in the UAE as well as the Increasing public and private wealth fuelled by the oil boom and strong healthcare infrastructure
- Drug consumption in the MENA region accounts for about 1.5% of the global total or around $ 9bn
- The UAE is 2nd in the region in terms of capital invested in the Pharma sector reliant on imports with more than 72 countries exporting Pharma products to UAE
- Highest-priced market in the region
- The pharmaceutical industry in the UAE also benefits from re-export markets as Iran, Pakistan, Yemen and Somalia which are the major buyers of re-exported pharmaceuticals from the UAE
- The Middle East’s pharmaceutical market is valued at more than US$12 billion and is expected to grow at a healthy %10-15, annually
- Within this amount the UAE is the considered to be the second-largest consumer of pharmaceutical products in the Gulf after Saudi Arabia with the market valued at around US$640 million
- GCC is currently home to one of the fastest growing populations in the world. The population is forecast to grow at a rate of 2.8% in the next 5 years to reach about 48 m by 2015
|
